Candace Whitfield
Nurse Practitioner · Honea Path, SCNPI 1710307103
Payments from drug & device makers
Across 398 payments — averaging $15.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Lilly USA, LLC$500
- AstraZeneca$489
- Novo Nordisk$468
- GSK$428
- Novartis$357
- plus $2K from 30 others
What the payments were for
- Food & beverage$6,08599%
- Education$891%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 122 | $1,520 |
| Lilly USA, LLC | 36 | $500 |
| AstraZeneca | 22 | $489 |
| Novo Nordisk | 33 | $468 |
| GSK | 22 | $428 |
| Novartis | 24 | $357 |
| Pfizer | 24 | $326 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 17 | $311 |
| Esperion Therapeutics, Inc. | 12 | $198 |
| Amgen | 11 | $176 |
| Abbott | 11 | $167 |
| Boehringer Ingelheim | 9 | $144 |
| Otsuka America Pharmaceutical, Inc. | 7 | $128 |
| Exact Sciences | 8 | $118 |
| Astellas Pharma US Inc | 2 | $104 |
| Lundbeck LLC | 4 | $102 |
| Axsome Therapeutics, Inc. | 4 | $88 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $68 |
| Edwards Lifesciences | 2 | $63 |
| Dexcom, Inc. | 4 | $59 |
| Daiichi Sankyo Inc. | 2 | $46 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $46 |
| Vanda Pharmaceuticals Inc. | 1 | $32 |
| Idorsia Pharmaceuticals US Inc | 2 | $28 |
| Sanofi-aventis U.S. LLC | 2 | $26 |
| Ultragenyx Pharmaceutical Inc. | 1 | $24 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $20 |
| Biohaven Pharmaceuticals, Inc. | 1 | $19 |
| E.r. Squibb & Sons, L.L.C. | 1 | $18 |
| Sunovion Pharmaceuticals Inc. | 1 | $18 |
| Dynavax Technologies Corporation | 1 | $16 |
| Merck | 1 | $14 |
| Nestle Healthcare Nutrition Inc. | 1 | $13 |
| Eisai Inc. | 1 | $13 |
| Medtronic | 1 | $13 |
| Phathom Pharmaceuticals, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,174 in reported general payments places this provider in the 95th percentile of 1,346 nurse practitioner providers in South Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 92 | $110,910 |
| EliquisApixaban | 92 | $88,931 |
| JardianceEmpagliflozin | 68 | $81,111 |
| MounjaroTirzepatide | 32 | $35,401 |
| Repatha SureclickEvolocumab | 36 | $33,554 |
| EntrestoSacubitril/Valsartan | 31 | $33,351 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 38 | $30,628 |
| VraylarCariprazine Hcl | 18 | $28,015 |
| TrulicityDulaglutide | 16 | $25,870 |
| Tresiba Flextouch U-200Insulin Degludec | 23 | $23,889 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 25 | $19,452 |
| LinzessLinaclotide | 27 | $19,083 |
| FarxigaDapagliflozin Propanediol | 13 | $14,799 |
| GlyxambiEmpagliflozin/Linagliptin | 12 | $6,837 |
| Ezetimibe | 137 | $6,526 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $468 | $110,91092 claims |
| PfizerEliquis | $326 | $88,93192 claims |
| Boehringer IngelheimJardiance, Glyxambi | $144 | $87,94880 claims |
| Lilly USA, LLCMounjaro, Trulicity | $500 | $61,27148 claims |
| AbbVieVraylar, Linzess | $1,520 | $47,09945 claims |
| AstraZenecaBreztri Aerosphere, Farxiga | $489 | $34,25138 claims |
| NovartisEntresto | $357 | $33,35131 claims |
| GSKTrelegy Ellipta | $428 | $30,62838 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,346 nurse practitioner providers in South Carolina.
Other nurse practitioner in Honea Path
- Jenna DavisColumbia$202K
- David WiltGreenville$90K
- Whitney ReedCharleston$54K
- Mary JohnsonCharleston$34K
- Amanda HareCharleston$30K
- Kellie McLainCharleston$28K
- Colleen BoydSummerville$21K
- Mae BurtonGreenville$21K
- Melissa BramanteColumbia$19K
- Gail KirbyGreer$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.